Methods of Colonic Transendoscopic Enteral Tubing

February 22, 2020 updated by: Faming Zhang, The Second Hospital of Nanjing Medical University

Methods of Colonic Transendoscopic Enteral Tubing: a Multicenter, Randomized Controlled Trial

Colonic transendoscopic enteral tubing (TET) is a novel, safe, convenient, and reliable way for fecal microbiota transplantation (FMT) and the whole-colon enema treatment. The aim of this study was to evaluate the methodology, efficiency, feasibility and safety of using transparent cap-assisted endoscopy for colon TET implantation.

Study Overview

Detailed Description

Our previous article has reported the method of colon TET. However, the investigators found that it was difficult to find the cavity because of the concentration of intestinal folds caused by the tube pulling after insertion of TET. It is well known that transparent cap-assisted colonoscopy is easier to flatten the semilunar folds and improve mucosal exposure. Here the investigators test the hypothesis that using transparent cap-assisted colonoscopy significantly decreases the second cecal intubation time which not only improve work efficiency, but also saves patients' anesthesia time and cost. Thus, the investigators design a prospective multicenter, randomized controlled trial. The aim of this study was to evaluate the methodology, efficiency, feasibility and safety of using transparent cap-assisted endoscopy for colon TET implantation.

Study Type

Interventional

Enrollment (Anticipated)

207

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Jiangsu
      • Nanjing, Jiangsu, China, 210011
        • Recruiting
        • Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University
      • Nanjing, Jiangsu, China, 210011
        • Recruiting
        • Fmt-Dt-N-27/1350
        • Contact:
          • Faming Zhang, PhD,MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years and older (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diseases requiring total colonic administration and fecal microbiota transplantation.
  • Patients and healthy Volunteers with the need to sample in deep colon .
  • Age > 7 years.
  • Must be able to Colonic Transendoscopic Enteral Tubing and no contraindication by endoscopic examination, consent colon TET implantation and not associated with severe intestinal lesions such as fistula, stenosis, complex perianal lesions, severe ileocecal or ascending colon lesions resulting in no proper site for titanium clip fixation.

Exclusion Criteria:

  • Data was not recorded as required; Before and after implantation is not the same physician operation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: HEALTH_SERVICES_RESEARCH
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: non-transparent cap-assisted endoscopic intubation
we do not use transparent cap-assisted endoscopic intubation.
The procedure colonic transendoscopic enteral tubing is as follows:The TET tube was inserted into the ileocecal junction through the endoscopy channel at the first time of the cecal intubation after examination and evaluation of the whole colon. Then, the colonoscope was removed from the colon while the TET tube was maintained at the ileocecal junction. Then the endoscopy was inserted into the ileocecum again for affixing the TET tube to cecum with titanium clips.
OTHER: transparent cap-assisted endoscopic intubation
we use transparent cap-assisted endoscopic intubation in the second insertion.
The procedure colonic transendoscopic enteral tubing is as follows:The TET tube was inserted into the ileocecal junction through the endoscopy channel at the first time of the cecal intubation after examination and evaluation of the whole colon. Then, the colonoscope was removed from the colon while the TET tube was maintained at the ileocecal junction. Then the endoscopy was inserted into the ileocecum again for affixing the TET tube to cecum with titanium clips.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The second cecal intubation time
Time Frame: one day
Record the time of colonoscopy from the anus to the ileal flap in the second insertion.
one day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adverse events rate
Time Frame: All patients were followed up from date of intubation to one mouth after discharge
Procedure-related and tube-related adverse events after procedure
All patients were followed up from date of intubation to one mouth after discharge
TET success rate
Time Frame: one day
The success rate of of the TET procedure
one day
Maximum insertion pain score
Time Frame: one day
Using numerical rating scale to evaluate maximum insertion pain score in non anesthesia. The digital grading method uses 0-10 to represent different levels of pain, with 0 as painless and 10 as severe. The classification standard of pain degree is: 0: no pain; 1-3: mild pain; 4-6: moderate pain; 7-10: severe pain.
one day
Retention time of tube
Time Frame: three month
Retention time of colonic transendoscopic enteral tubing
three month
Tubing time
Time Frame: one day
The tubing time is from advancement of the TET tube through the channel to the end of the tubing.
one day
Titanium clip fixation time
Time Frame: one day
Record the time required for fixing a titanium clip.
one day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Faming Zhang, MD; PHD, Nanjing Medical University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 10, 2018

Primary Completion (ANTICIPATED)

May 10, 2020

Study Completion (ANTICIPATED)

May 10, 2020

Study Registration Dates

First Submitted

August 5, 2018

First Submitted That Met QC Criteria

August 5, 2018

First Posted (ACTUAL)

August 8, 2018

Study Record Updates

Last Update Posted (ACTUAL)

February 25, 2020

Last Update Submitted That Met QC Criteria

February 22, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colonic Transendoscopic Enteral Tubing

Clinical Trials on colonic transendoscopic enteral tubing

Subscribe